FDA : Shots - Health News FDA
Stories About

FDA

AIDS activist group ACT UP organized numerous protests on Wall Street in the 1980s. The group's tactics helped speed the process of finding an effective treatment for AIDS. Tim Clary/AP hide caption

toggle caption
Tim Clary/AP

How To Demand A Medical Breakthrough: Lessons From The AIDS Fight

  • Download
  • <iframe src="https://www.npr.org/player/embed/689924838/692955908" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Rep. John Dingell was seated next to President Barack Obama when he signed the Affordable Care Act into law at the White House on March 23, 2010. Chip Somodevilla/Getty Images hide caption

toggle caption
Chip Somodevilla/Getty Images

Shoppers say they want simpler information to help them figure out which foods are healthy. But a one-size-fits-all solution may not work. asiseeit/Getty Images hide caption

toggle caption
asiseeit/Getty Images

Juul Labs, the maker of e-cigarettes popular with young, has come under fire from health officials. Since the spring of 2018 the company has been lobbying the federal government. Gabby Jones/Getty Images hide caption

toggle caption
Gabby Jones/Getty Images

Costco Wholesale requires its food suppliers to undergo annual inspections and requires some produce suppliers to hold shipments until tests come back negative for disease-causing bacteria. Mark Peterson/Corbis via Getty Images hide caption

toggle caption
Mark Peterson/Corbis via Getty Images

Don't Panic: The Government Shutdown Isn't Making Food Unsafe

  • Download
  • <iframe src="https://www.npr.org/player/embed/684589220/684748540" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Susie Christoff tried several drugs to cope with her painful psoriatic arthritis before finding Cosentyx worked the best. The problem was the cost. Chris Bartlett/for Kaiser Health News hide caption

toggle caption
Chris Bartlett/for Kaiser Health News

Why The U.S. Remains The Most Expensive Market For 'Biologic' Drugs In The World

  • Download
  • <iframe src="https://www.npr.org/player/embed/676401634/678815311" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A U.S. park ranger gives a tourist suggestions of other nearby places to visit while Joshua Tree National Park was shut down in 2013. Robyn Beck/AFP/Getty Images hide caption

toggle caption
Robyn Beck/AFP/Getty Images

Here's What Would Happen If The Government Shuts Down This Week

  • Download
  • <iframe src="https://www.npr.org/player/embed/676689450/677511406" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The Food and Drug Administration has seen a sharp increase in applications for drug to treat rare diseases. An oversight report found problems with how agency is handling them. Al Drago/CQ Roll Call/Getty Images hide caption

toggle caption
Al Drago/CQ Roll Call/Getty Images

FDA Commissioner Scott Gottlieb said he wants to ban menthol cigarettes because teenagers often become addicted to nicotine by smoking them. Joe Raedle/Getty Images hide caption

toggle caption
Joe Raedle/Getty Images

FDA Seeks Ban On Menthol Cigarettes To Fight Teen Smoking

  • Download
  • <iframe src="https://www.npr.org/player/embed/668192356/668380527" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

There's been an increase in vaping in teens, but e-cigarette manufacturers say it's a safer alternative to smoking. Martina Paraninfi/Getty Images hide caption

toggle caption
Martina Paraninfi/Getty Images

FDA Cracks Down On E-Cigarette Sales To Curb Teen Vaping

  • Download
  • <iframe src="https://www.npr.org/player/embed/666295593/666345227" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Food and Drug Administration Commissioner Scott Gottlieb, testifying before a House subcommittee in May. There are "very tight restrictions" being placed on the distribution and use of Dsuvia, Gottlieb said Friday in addressing the FDA's approval of the new opioid. But critics of the FDA decision say the drug is unnecessary. Chip Somodevilla/Getty Images hide caption

toggle caption
Chip Somodevilla/Getty Images